2008
DOI: 10.1128/iai.00686-08
|View full text |Cite
|
Sign up to set email alerts
|

RecombinantBacillus subtilisExpressing theClostridium perfringensAlpha Toxoid Is a Candidate Orally Delivered Vaccine against Necrotic Enteritis

Abstract: Recombinant Bacillus subtilis endospores have been used to vaccinate against tetanus and anthrax. In this work, we have developed spores that could be used to vaccinate against Clostridium perfringens alpha toxin and that could be used to protect against gas gangrene in humans and necrotic enteritis in poultry. The primary active agent in both cases is alpha toxin. A carboxy-terminal segment of the alpha toxin gene (

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
50
0
2

Year Published

2011
2011
2022
2022

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 83 publications
(52 citation statements)
references
References 40 publications
0
50
0
2
Order By: Relevance
“…It is possible that our prototype vaccines simply do not elicit sufficiently high toxin B-neutralizing titers, possibly due to B15-24 being displayed in a partially denatured form that impairs the generation of appropriate neutralizing antibodies. This may reflect the action of its fusion partner, the spore coat protein CotB, although this has been used successfully previously (8,13). Full protection to challenge using PP108 spores might be achieved either by changing the dosing regimen or by increasing the dose of heterologous protein expression (whether of A26-39 and/or of B15-24).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…It is possible that our prototype vaccines simply do not elicit sufficiently high toxin B-neutralizing titers, possibly due to B15-24 being displayed in a partially denatured form that impairs the generation of appropriate neutralizing antibodies. This may reflect the action of its fusion partner, the spore coat protein CotB, although this has been used successfully previously (8,13). Full protection to challenge using PP108 spores might be achieved either by changing the dosing regimen or by increasing the dose of heterologous protein expression (whether of A26-39 and/or of B15-24).…”
Section: Discussionmentioning
confidence: 99%
“…In experiments using spores expressing antigens on their surface coats, they have been shown to protect mice immunized against tetanus toxin from Clostridium tetani (8) and Clostridium perfringens alpha toxin (13). In both cases, significant levels of local immunity (sIgA) were induced.…”
mentioning
confidence: 95%
“…Practical delivery methods, such as infeed, drinking water or spray application, have not yet been tested. Recombinant B. subtilis endospores that express the C-terminal domain of alpha toxin have been used to vaccinate mice against C. perfringens infection (Hoang et al, 2008). The endospores appear to provide an adjuvant effect, boosting the immune response to the antigens.…”
Section: The Future Of Vaccine Delivery and Immunization Methods For mentioning
confidence: 99%
“…While Salmonella strains are thus potential vaccine carriers for C. perfringens proteins, there are other possibilities that, although not yet explored for protection of poultry against necrotic enteritis, may be of value. The expression of the C-terminal domain of alpha toxin on the surface of Bacillus subtilis spores was described and shown to be immunogenic in mice (Hoang et al, 2008). Lactic acid bacteria can be used as vaccine carriers for Clostridium antigens (Robinson et al, 1997(Robinson et al, , 2004.…”
Section: An Overview Of Vaccination Studies Against Necrotic Enteritismentioning
confidence: 99%
“…Επί σης, ο εμβολιασμός μυών με το καρβοξυλικό άκρο (C terminal domain) της τοξίνης -α διέγειρε το ανο σοποιητικό σύστημα και προκάλεσε την παραγωγή εξουδετερωτικών αντισωμάτων, τα οποία ήταν προ στατευτικά έναντι της μόλυνσης με C. perfringens (Hoang et al 2008, Zekarias et al 2008). …”
Section: δεδομένα που ενισχύουν τον ρόλο της τοξίνης -α στην παθογένεunclassified